MSF calls again on J&J to withdraw or abandon extended patents on lifesaving TB drug as main patent expires in India 0 19.07.2023 11:20 The Hindu Johnson & Johnson’s 20-year primary patent on the critical, lifesaving drug-resistant tuberculosis (DR-TB) drug bedaquiline expired on July 18 in most countries, including India Партнёры Smi24.net Все новости за 24 часа Музыкальные новости Агрегатор новостей 24СМИ
